Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ – Equities.com

Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ – Equities.com

Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ
Equities.com
TUSTIN, CA — (Marketwire) — 11/14/12 — Peregrine Pharmaceuticals (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, announced that it received today a

and more »

0
Like
Save

Comments

Comments are disabled for this post.